BridgeMD
New treatment option for Chemotherapy-induced Peripheral Neuropathy (CIPN)
Official title Effect of Adding Electroacupuncture to Anti-cancer Therapy-induced Peripheral Neuropathy
ClinicalTrials.gov ID: NCT06858709
What this study is testing
- What it's testing
- This study is being done to evaluate the potential benefits of using electroacupuncture to reduce the severity of chemotherapy-induced peripheral neuropathy for patients with peripheral neuropathy after chemotherapy.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- 18 years of age or older, of any nationality.
- Patients diagnosed with malignant tumor.
- Eligible patients will report altered sensations and/or pain and/or other neurological symptoms, with a grade between 2-3 for chemotherapy-induced...
- Predicted life expectancy of ≥3 months.
- Intact skin without any breaches or purulent discharge.
You likely can't join if
- History of pre-existing peripheral neuropathy before chemotherapy, including alcoholism, vitamin B deficiency, diabetes, HIV, congenital neuropathy...
- Patients with skin damage, pus or scar at the acupuncture stimulation area.
- Patients who are pregnant or breastfeeding.
- Significant mental conditions.
- Patients not fulfilling the inclusion criteria.
- Patients receiving other acupuncture treatments during the trial.
See the full eligibility criteria
- 18 years of age or older, of any nationality.
- Patients diagnosed with malignant tumor.
- Eligible patients will report altered sensations and/or pain and/or other neurological symptoms, with a grade between 2-3 for chemotherapy-induced peripheral neuropathy on the National Cancer Institute (NCI) Common...
- Predicted life expectancy of ≥3 months.
- Intact skin without any breaches or purulent discharge.
- Written informed consent by the patient before enrolment Patients must be able to comply with the study protocol, which includes attending the treatment sessions on time and completing the study questionnaires in...
- History of pre-existing peripheral neuropathy before chemotherapy, including alcoholism, vitamin B deficiency, diabetes, HIV, congenital neuropathy, and toxic neuropathy.
- Patients with skin damage, pus or scar at the acupuncture stimulation area.
- Patients who are pregnant or breastfeeding.
- Significant mental conditions.
- Patients not fulfilling the inclusion criteria.
- Patients receiving other acupuncture treatments during the trial.
The study team makes the final eligibility decision.
Where it's taking place
- Wuhan, Hubei, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Wuhan, Hubei, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.